EndoQuest Robotics Secures $42M in Funding to Advance Flexible Endoluminal Robotic Technologies for Minimally Invasive Surgeries.
EndoQuest Robotics is pioneering the development of endoluminal robotic technologies aimed at transforming GI and other luminal surgeries.
Company Name: EndoQuest Robotics
Location: Houston, TX
Sector: Medical Device/Robotics
Funding Details: Raised $42M in C-1 funding, led by CE Ventures and McNair Interests, with Puma Venture Capital LLC as a new investor.
Purpose of Investment: To further R&D, achieve regulatory milestones, commercialize their technology, and solidify their leadership in flexible endoluminal robotics.
Leadership: CEO Kurt Azarbarzin
Product: An innovative robotic system for gastrointestinal (GI) and other endoluminal surgeries, designed to offer precision, flexibility, and improved patient outcomes with minimally invasive interventions.
About Company: EndoQuest Robotics is pioneering the development of endoluminal robotic technologies aimed at transforming GI and other luminal surgeries. Their focus on creating a flexible robotic system underscores their commitment to advancing minimally invasive surgical techniques and enhancing patient care.
Innovation and Impact:
- Flexible Robotic System: Targets the unmet needs in GI surgeries with a robotic system that emphasizes precision and minimally invasive procedures.
- Advancing Minimally Invasive Surgeries: Aims to improve patient outcomes by reducing recovery time and surgical complications.
- Enhancing Healthcare Professional Capabilities: Provides healthcare professionals with advanced tools for performing complex endoluminal procedures.
